X-16654475-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PP3_ModerateBS2
The NM_004057.3(S100G):āc.206A>Cā(p.Glu69Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000546 in 1,191,512 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00028 ( 0 hom., 7 hem., cov: 22)
Exomes š: 0.000031 ( 0 hom. 8 hem. )
Consequence
S100G
NM_004057.3 missense
NM_004057.3 missense
Scores
10
5
1
Clinical Significance
Conservation
PhyloP100: 4.60
Genes affected
S100G (HGNC:1436): (S100 calcium binding protein G) This gene encodes calbindin D9K, a vitamin D-dependent calcium-binding protein. This cytosolic protein belongs to a family of calcium-binding proteins that includes calmodulin, parvalbumin, troponin C, and S100 protein. In the intestine, the protein is vitamin D-dependent and its expression correlates with calcium transport activity. The protein may increase Ca2+ absorption by buffering Ca2+ in the cytoplasm and increase ATP-dependent Ca2+ transport in duodenal basolateral membrane vesicles. [provided by RefSeq, Jul 2008]
CTPS2 (HGNC:2520): (CTP synthase 2) The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM1
In a binding_site (size 0) in uniprot entity S100G_HUMAN
PP3
MetaRNN computational evidence supports a deleterious effect, 0.883
BS2
High Hemizygotes in GnomAd4 at 7 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
S100G | NM_004057.3 | c.206A>C | p.Glu69Ala | missense_variant | 3/3 | ENST00000380200.3 | NP_004048.1 | |
CTPS2 | NM_175859.3 | c.1296+13039T>G | intron_variant | ENST00000359276.9 | NP_787055.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
S100G | ENST00000380200.3 | c.206A>C | p.Glu69Ala | missense_variant | 3/3 | 1 | NM_004057.3 | ENSP00000369547 | P1 | |
CTPS2 | ENST00000359276.9 | c.1296+13039T>G | intron_variant | 1 | NM_175859.3 | ENSP00000352222 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000277 AC: 31AN: 112013Hom.: 0 Cov.: 22 AF XY: 0.000205 AC XY: 7AN XY: 34173
GnomAD3 genomes
AF:
AC:
31
AN:
112013
Hom.:
Cov.:
22
AF XY:
AC XY:
7
AN XY:
34173
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000732 AC: 13AN: 177613Hom.: 0 AF XY: 0.0000481 AC XY: 3AN XY: 62387
GnomAD3 exomes
AF:
AC:
13
AN:
177613
Hom.:
AF XY:
AC XY:
3
AN XY:
62387
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000315 AC: 34AN: 1079499Hom.: 0 Cov.: 24 AF XY: 0.0000231 AC XY: 8AN XY: 345835
GnomAD4 exome
AF:
AC:
34
AN:
1079499
Hom.:
Cov.:
24
AF XY:
AC XY:
8
AN XY:
345835
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000277 AC: 31AN: 112013Hom.: 0 Cov.: 22 AF XY: 0.000205 AC XY: 7AN XY: 34173
GnomAD4 genome
AF:
AC:
31
AN:
112013
Hom.:
Cov.:
22
AF XY:
AC XY:
7
AN XY:
34173
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
8
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2023 | The c.206A>C (p.E69A) alteration is located in exon 3 (coding exon 2) of the S100G gene. This alteration results from a A to C substitution at nucleotide position 206, causing the glutamic acid (E) at amino acid position 69 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at